Suchergebnisse - "Zhang, Yuntao"

PubPharm (8)

1

Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity

enthalten in: Virology | 2024

von Zheng, X. | Yang, R. | Zhao, Y. | +15

2

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine

enthalten in: Antiviral research | 2023

von Lu, C. | Zhang, Y. | Liu, X. | +30

3

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults

enthalten in: Frontiers of medicine | 2022

von Zhang, Y. | Yang, Y. | Qiao, N. | +8

4

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children : Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial

enthalten in: Frontiers in immunology | 2022

von Xia, S. | Duan, K. | Zhang, Y. | +35

5

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV : a randomised, double-blind, placebo-controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2021

von Xia, S. | Zhang, Y. | Wang, Y. | +29

6

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes : Interim Analysis of 2 Randomized Clinical Trials

enthalten in: JAMA | 2020

von Xia, S. | Duan, K. | Zhang, Y. | +34

CommentIn: JAMA. 2020 Sep 8;324(10):943-945. - PMID 32789500

7

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

enthalten in: Cell | 2020

von Wang, H. | Zhang, Y. | Huang, B. | +29

8

2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children : A Randomized Open-Label Study

enthalten in: The Journal of infectious diseases | 2017

von Wei, M. | Meng, F. | Wang, S. | +12

1
[1]